Science Current Events | Science News | Brightsurf.com
 

Liver Cancer Current Events | Liver Cancer News | 2

Sort By: Page Views | Date

HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia?
Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial.   view more (2009-09-16)

Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer
Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported today at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines. The team is currently designing a trial to test the combination in patients.   view more (2008-04-14)

Largest-ever database for liver proteins may lead to treatments for hepatitis
Scientists at a group of 11 research centers in China are reporting for the first time assembly of the largest-ever collection of data about the proteins produced by genes in a single human organ.   view more (2009-11-12)

Should living liver donation be available in the NHS?
Living liver donation should be available on the NHS, although it should not be adopted without full public debate and agreement because of the risks to donors, argue researchers in this week's BMJ. Living liver donation could benefit patients who are likely to die or deteriorate before a cadaveric donor becomes available. It involves a minimum... view more... (2003-09-17)

1 surgery better than 2 for some colorectal cancer patients
A single surgery to remove cancer from both the colon and the liver to which it has spread may be better in some cases than the current standard treatment of two separate surgeries with chemotherapy in between, according to a study led by Duke University Medical Center researchers.   view more (2007-03-19)

Targeting Tumor Behavior May Lead To New Liver Cancer Drugs
Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior.   view more (2009-06-19)

Cycles of cell death, proliferation key to liver cancer
Research at the University of California, San Diego (UCSD) School of Medicine shows that liver cancer is likely caused by cycles of liver cell death and renewal.   view more (2006-06-23)

Women given liver transplants outlive male recipients by around 4 years
Female liver transplant recipients outlive men given the same procedure by an average of 4.5 years, suggests research published ahead of print in Gut.   view more (2006-09-28)

Nexavar shown to significantly extend survival for patients with advanced liver cancer
Bayer Pharmaceuticals Corporation (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that an independent data monitoring committee (DMC) has reviewed the safety and efficacy data from the companies' pivotal Phase 3 trial in patients with advanced hepatocellular carcinoma (HCC), or primary liver cancer.   view more (2007-02-13)

Antibody retards growth and induces death in liver cancer cells
Researchers from the University of Pittsburgh School of Medicine report a significant new advance in the search for an effective treatment for human liver cancer in the July issue of Molecular Cancer Therapeutics.   view more (2007-07-12)

Scots and Irish at greater risk of drink-related death, study shows
Alcohol-related deaths in England and Wales are twice as high among people born in Scotland or Ireland compared with the rest of the population, a study has shown.   view more (2009-03-19)

New Jefferson Trial to Test Radiation-Emitting Beads Against Advanced Liver Cancer
Liver cancer specialists at Jefferson's Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver's main artery while also blocking the blood supply feeding the cancer's growth.   view more (2008-02-13)

New therapy shows promise for fighting treatment-resistant cancer cells
A gene radiotherapy system that detects and treats cancer cells that are resistant to traditional forms of chemotherapy and radiation showed success in the laboratory and could eventually prove beneficial for cancer patients, according to researchers at SNM's 55th Annual Meeting.   view more (2008-06-17)

Is bilateral liver resection safe for bilateral intrahepatic stones?
A research article to be published on August 7, 2009 in the World Journal of Gastroenterology addresses this question. In the present study, 101 consecutive patients with bilateral intrahepatic stones who underwent bilateral liver resection in the past 10 years were reviewed retrospectively.   view more (2009-08-06)

Incidence of Fatty Liver Disease rises as obesity in children increases
Indiana University School of Medicine researchers are taking a closer look at a disease whose incidence is rising as obesity in children increases. Non-Alcoholic Steatohepatitis, more popularly known as Fatty Liver Disease, occurs in approximately 15% of obese children.   view more (2007-03-16)

"Suicide gene" injection shrinks cancer growth
Injectable "suicide gene" therapy may be a highly effective way of preventing colon cancer from spreading (metastasising), finds research in Gut. Human colon cancer carries a high risk of death because it is often not found in the early stages and readily spreads to the liver, but also the lungs and throughout the abdominal cavity (peritoneum).   view more (2002-02-08)

Study shows liver an excellent target for cancer gene therapy using viral vectors
A featured paper in the February 14 issue of Nature Cancer Gene Therapy demonstrates that cancer cells in the liver are excellent targets for gene therapy using adenoviral vectors, based upon a fundamental new understanding of the differences between cancerous and normal liver cells.   view more (2007-02-15)

A new player in the battle against hepatitis prevents inflammation and the death of liver cells
Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) have again achieved a breakthrough in research on hepatitis.   view more (2005-09-02)

Combining liver cancer treatments doubles survival rates, UVA researchers find
By combining the use of stents and photodynamic therapy, also called SpyGlass, physicians at the University of Virginia have been able to significantly increase survival rates for patients suffering from advanced cholangiocarcinoma, cancer of the liver bile duct.   view more (2008-04-16)

Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
New research published in the Journal of the American College of Surgeons shows long-term survival and liver rejection rates are equivalent for African-American liver transplant patients as compared with patients of other races.   view more (2008-05-20)
Sort By: Page Views | Date
© 2009 BrightSurf.com